Even though lung cancer is one of the most prevalent diseases, with an increasing incidence as well as the continued occurrence of morbidity and death, our clinical practice needs to consider a wide range of factors when determining the most appropriate treatment option for patie...
Open access
Research Article10.9734/jcti/2025/v15i4334
Background: Cancer is listed among the leading causes of mortality and morbidity worldwide, with approx 19.97 million newly diagnosed cases and 9.74 million cancer deaths in 2022. 6,66,103 cases died out of 2.29 million new cases of breast cancer diagnosed in 2022. Radiotherapy...
Open access
Research Article10.9734/jcti/2025/v15i4333
Background: Ovarian sex cord stromal tumors (SCSTs) are rare neoplasms accounting for 5-8% of all ovarian malignancies. Giant variants (>10 cm) are exceptional and mimic epithelial tumors clinically and radiologically. Aim and Objective: To systematically review the clinical,...
Open access
Research Article10.9734/jcti/2025/v15i4332
Background: Cervical cancer remains a consequential global public health challenge, mainly driven by persistent human papillomavirus (HPV) infection. In low-resource contexts such as Nakuru County, Kenya, incidence and mortality rates are high, with conventional screening methods...
Open access
Research Article10.9734/jcti/2025/v15i4331
Schwannomas are benign peripheral nerve sheath tumors most frequently found in the head and neck region. Their occurrence in the nasolabial area, however, is exceedingly rare. We reported this case, a 27-year-old man presenting with a gradually enlarging right-sided nasal swellin...
Open access
Research Article10.9734/jcti/2025/v15i4330
Circulating tumor DNA (ctDNA) is a type of cell-free DNA that originates from the shedding of tumor cells to the bloodstream and has recently been considered as a potential biomarker in colorectal cancer (CRC). This review covers the general features of ctDNA in terms of their bi...
Open access
Research Article10.9734/jcti/2025/v15i4329
Chukwum J. Okafor, Bart I. Ifionu, Ufuoma Ohwo, Nkem F. Obianagha, Emmanuel I. Obeagu, Omobolanle Abioye Ogundahunsi, E. N Adejumo & Seyi Samson Enitan·Journal of Cancer and Tumor International·2025
Introduction: Prostatic diseases, including prostate cancer (CAP) and benign prostatic hyperplasia (BPH), are prevalent pathologies in ageing men. While prostate-specific antigen (PSA) is a well-established diagnostic marker, the role of serum testosterone in distinguishing betwe...
Open access
Research Article10.9734/jcti/2025/v15i4328
Prostate cancer remains the second most common malignancy among men worldwide and a leading cause of cancer-related mortality. MicroRNAs (miRNAs) and genomic signatures are critical regulators of oncogenic processes and represent promising biomarkers for cancer diagnosis and prog...
Open access
Research Article10.9734/jcti/2025/v15i4327
Ahoma Victor Mbanuzuru, Samuel I. Udobi, Christian Chibuzor Ibeh, Chinyere Mbanuzuru & Chukwuemeka Chukwubuikem Okoro·Journal of Cancer and Tumor International·2025
There is rapid growth and expansion of Telecommunication industry and infrastructures worldwide. In sub-Sahara Africa this has led to increased erection of base transceiver stations (BTS) often close to residential areas. The siting of telecommunication masts around residential b...
Open access
Research Article10.9734/jcti/2025/v15i4326
Background: Ovarian cancer is frequently diagnosed at advanced stages, requiring reliable and minimally invasive diagnostic tools. Fine Needle Aspiration Cytology (FNAC) has been proposed as a rapid and cost-effective method, but institutional data are essential to validate its r...
Open access
Research Article10.9734/jcti/2025/v15i4325